From the *Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and
†Miami Itch Center, University of Miami Miller School of Medicine, FL; and
‡Departments of Dermatology, Preventive Medicine, and Medical Social Sciences, Feinberg School of Medicine at Northwestern University; and
§Northwestern Medicine Multidisciplinary Eczema Center, Chicago, IL.
Address reprint requests to Gil Yosipovitch, MD, 1600 NW 10th Ave, RMSB 2067B, Miami, FL 33136. E-mail: email@example.com.
G.Y. has been a consultant or advisory board member of Menlo, TREVI, Sienna, Galderma, Sanofi, Regeneron, Novartis, Eli Lilly, and Pfizer and received research grants from Sun Pharma, Pfizer, and Leo Foundation. J.I.S. served as a consultant and/or advisory board member for Abbvie, Asana, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, Leo, Menlo, Pfizer, Regeneron-Sanofi, Realm, and Roivant for granting honoraria and as speaker for Regeneron-Sanofi and received research grants from GlaxoSmithKline and Regeneron-Sanofi. J.I.S. is supported by the DermatologyFoundation.